Cargando…
Harada-like syndrome post-Covishield vaccination: A rare adverse effect
Covishield is in wide use in India with about 80% efficacy. Serious side effects are still under study. A 30-year-old female presented to us 7 days post-vaccination with a 5-day history of sudden diminution of vision in both eyes. The clinical findings were suggestive of the Vogt-Koyanagi-Harada (VK...
Autores principales: | Reddy, Yogya, Pandey, Anamika, Ojha, Ayushi, Ramchandani, Suresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917518/ https://www.ncbi.nlm.nih.gov/pubmed/34937269 http://dx.doi.org/10.4103/ijo.IJO_2589_21 |
Ejemplares similares
-
Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) – A case report and review of literature
por: Rajagopal, Rama, et al.
Publicado: (2022) -
Vogt Koyanagi Harada disease following a recent COVID-19 infection
por: Anthony, Eliza, et al.
Publicado: (2022) -
A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients
por: Polhemus, David J., et al.
Publicado: (2015) -
Central retinal vein occlusion post-COVID-19 vaccination
por: Sonawane, Nikita J, et al.
Publicado: (2022) -
Psychosocial assessment among ophthalmic patients attending tertiary eye care centre during the lockdown in times of COVID-19 pandemic
por: Sanjay, Srinivasan, et al.
Publicado: (2022)